Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-26 @ 4:24 AM
Study NCT ID:
NCT04824092
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-08
First Post:
2021-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-22
First Submit QC Date:
None
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED